Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Arthritis, Psoriatic 1

Interventions

guselkumab 3 tofacitinib 1 sonelokimab 1 risankizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Arthritis, Psoriatic × sonelokimab × Clear all

NCT06641089 2026-05-18

IZAR-2

MoonLake Immunotherapeutics AG

Phase 3 Recruiting

Arthritis, Psoriatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡